PO-55 - Individual variation in hemostatic alterations caused by tyrosine kinase inhibitors - a way to improve personalized cancer therapy? - Deb, S; Sjöström, C; Tharmakulanathan, A; Boknäs, N; Lotfi, K; Ramström, S (Thromb Res, 2016)